Hepatitis Delta: Current Knowledge and Future Directions

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Hepatitis delta virus (HDV) is a unique circular RNA virus dependent on hepatitis B virus (HBV) for its life cycle.
• HDV infection, as coinfection or superinfection with HBV, causes the most severe form of viral hepatitis.
• Chronic HDV infection leads to significant global morbidity and mortality.

Purpose of the Study:

• To review the global and US epidemiology of HDV infection.
• To outline the diagnosis and clinical progression of HDV.
• To discuss current and emerging therapeutic strategies for HDV.

Main Methods:

• Literature review of epidemiological data.
• Analysis of clinical case studies and outcomes.
• Survey of existing and investigational treatments for HDV.

Main Results:

• HDV infection presents a substantial global health burden, particularly in HBV-infected populations.
• Diagnosis relies on serological markers and viral load detection.
• Limited therapeutic options currently exist, with significant unmet needs.

Conclusions:

• Chronic HDV infection represents a severe liver disease with poor outcomes.
• Effective management strategies are scarce, necessitating further research and development.
• Future therapies are crucial to improve patient outcomes and reduce mortality.